Skip to main content
. 2015 Jul 31;7(1):224–240. doi: 10.18632/oncotarget.4399

Table 3. Sample description for the tumor and normal biopsies used for miRNA profiling.

Samples Disease Subtype EBER EBV latency
BL_001 BL Sporadic NEG NA
BL_002 BL Sporadic NEG NA
BL_003 BL Sporadic NEG NA
BL_004 BL Sporadic NEG NA
BL_007 BL Sporadic NEG NA
BL_008 BL Sporadic NEG NA
BL_010 BL Sporadic NEG NA
BL_012 BL Sporadic NEG NA
BL_020 BL Endemic NEG NA
BL_023 BL Immunodeficiency-related NEG NA
BL_024 BL Immunodeficiency-related NEG NA
BL_025 BL Immunodeficiency-related NEG NA
BL_030* BL Immunodeficiency-related NEG NA
BL_005 BL Sporadic POS Type I
BL_006 BL Sporadic POS Type I
BL_009 BL Sporadic POS Type I
BL_011 BL Sporadic POS Type I
BL_013 BL Sporadic POS Type I
BL_014 BL Endemic POS Type I
BL_015 BL Endemic POS Type I
BL_016 BL Endemic POS Type I
BL_017 BL Endemic POS Type I
BL_018 BL Endemic POS Type I
BL_019 BL Endemic POS Type I
BL_021 BL Endemic POS Type I
BL_022 BL Immunodeficiency-related POS Type I
BL_026 BL Immunodeficiency-related POS Type I
BL_027 BL Immunodeficiency-related POS Type I
BL_028 BL Immunodeficiency-related POS Type I
BL_029 BL Immunodeficiency-related POS Type I
PTLD_031 PTLD DLBCL POS Type III
PTLD_032 PTLD DLBCL POS Type III
PTLD_033 PTLD DLBCL POS Type III
PTLD_034 PTLD DLBCL POS Type III
PTLD_035 PTLD DLBCL POS Type III
MNC_036 Lymphadenopathy Lymphadenopathy POS Type I
MNC_037 Lymphadenopathy Lymphadenopathy POS Type I
*

Not used in miRNA profiling.

NA: not available